In this study, JNK signaling activity was markedly increased following combined treatment with ixazomib and dinaciclib and played a functional role in mediating the pro-apoptotic effects of Ixa + Dina in HCC tumor cells. The gene discussed is MAPK8; the disease is neoplasm.